AbbVie, Inc.
(NYSE : ABBV)

( )
ABBV After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
MRKMerck & Co., Inc. 0.64%81.670.7%$1580.82m
JNJJohnson & Johnson 0.24%164.110.7%$1029.23m
PFEPfizer Inc. 0.02%43.170.9%$920.88m
ABBVAbbVie, Inc. -0.50%108.601.9%$660.30m
BMYBristol-Myers Squibb Co. 0.33%57.791.0%$632.94m
LLYEli Lilly & Co. 0.59%245.191.1%$607.90m
AZNAstraZeneca Plc -0.03%61.771.0%$288.96m
NVSNovartis AG -1.83%83.370.2%$174.15m
GSKGlaxoSmithKline Plc 0.08%39.800.2%$162.18m
AVIRAtea Pharmaceuticals, Inc. -0.08%12.720.3%$130.94m
RGENRepligen Corp. -0.10%274.676.8%$111.12m
VTRSViatris, Inc. -1.00%13.800.0%$90.95m
NVONovo Nordisk A/S 0.13%106.150.1%$90.14m
SNYSanofi -0.26%49.790.2%$65.48m
OGNOrganon & Co. 3.45%36.890.0%$53.15m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.